Zobrazeno 1 - 10
of 121
pro vyhledávání: '"A. L. Sabichi"'
Autor:
Ola Soliman, David C. Wilde, Jan O. Kemnade, Anita L. Sabichi, George Chen, Albert Chen, Samantha N. Little, Andrew T. Huang, David J. Hernandez, Vlad C. Sandulache
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 8, Iss 4, Pp 895-902 (2023)
Abstract Objective Cisplatin forms the backbone of systemic chemotherapy treatment for oropharyngeal squamous cell carcinoma (OPSCC). The ideal cisplatin dosing regimen remains yet to be fully defined for achieving optimal efficacy and toxicity profi
Externí odkaz:
https://doaj.org/article/63e9ba405d214ea08428bffef1d69cc1
Publikováno v:
OncoImmunology, Vol 8, Iss 12 (2019)
Background: Immune checkpoint inhibitors (ICIs) have dramatically expanded the therapeutic landscape of non-small-cell lung cancer (NSCLC). In a previous study, gender, smoking history, and PD-L1 status were found to influence the efficacy of single-
Externí odkaz:
https://doaj.org/article/feaf40a6358140bdab7f92400c0f7427
Autor:
Marcus A. Florez, Jan O. Kemnade, Nan Chen, Wendy Du, Anita L. Sabichi, Daniel Y. Wang, Quillan Huang, Courtney N. Miller-Chism, Aparna Jotwani, Albert C. Chen, David Hernandez, Vlad C. Sandulache
Publikováno v:
Cancer Res Commun
We reviewed response to immune checkpoint inhibitors (ICI) of 207 patients with diagnoses of lung or head and neck cancer treated with chemotherapy/ICI combination therapy and ICI monotherapy between 2015 and 2020 at one of three clinical pavilions a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029ba1f46bf4925c45898e45209901d6
https://doi.org/10.1158/2767-9764.crc-21-0143
https://doi.org/10.1158/2767-9764.crc-21-0143
Autor:
Quillan, Huang, Jan, Kemnade, Loraine, Cornwell, Farrah, Kheradmand, Anita L, Sabichi, Devika, Das
Publikováno v:
Seminars in Oncology. 49:337-343
Immunotherapy for non-small cell lung cancer (NSCLC) has revolutionized treatment for those with advanced disease, and recent data have emerged providing evidence for its benefits in earlier stages of the disease. Several pivotal clinical trials prov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c0d8eb73a146be839dc335045353e3
https://doi.org/10.1053/j.seminoncol.2022.06.009
https://doi.org/10.1053/j.seminoncol.2022.06.009
Autor:
Vlad C. Sandulache, David Hernandez, Albert C. Chen, Aparna Jotwani, Courtney N. Miller-Chism, Quillan Huang, Daniel Y. Wang, Anita L. Sabichi, Wendy Du, Nan Chen, Jan O. Kemnade, Marcus A. Florez
Combined supplementary data file.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad9692a7ab17ef13e17bec4885e267b9
https://doi.org/10.1158/2767-9764.22545324.v1
https://doi.org/10.1158/2767-9764.22545324.v1
Autor:
Vlad C. Sandulache, David Hernandez, Albert C. Chen, Aparna Jotwani, Courtney N. Miller-Chism, Quillan Huang, Daniel Y. Wang, Anita L. Sabichi, Wendy Du, Nan Chen, Jan O. Kemnade, Marcus A. Florez
We reviewed response to immune checkpoint inhibitors (ICI) of 207 patients with diagnoses of lung or head and neck cancer treated with chemotherapy/ICI combination therapy and ICI monotherapy between 2015 and 2020 at one of three clinical pavilions a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6c6c928ac0b7b8e0fb9c1aa441e78e
https://doi.org/10.1158/2767-9764.c.6550908
https://doi.org/10.1158/2767-9764.c.6550908
Autor:
Seth P. Lerner, J. Lynn Palmer, Jaye L. Viner, Craig Eagle, Jorge De la Cerda, Bogdan A. Czerniak, Ellen Richmond, Suyu Liu, H. Barton Grossman, J. Jack Lee, Anita L. Sabichi
Significant morbidity and expense result from frequent recurrences of nonmuscle-invasive bladder cancer (NMIBC) after standard treatment, and carcinoma in situ (Tis) is a poor prognostic factor. Predicated on observational and preclinical data strong
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09d873711b9947391aa80303183eefc1
https://doi.org/10.1158/1940-6207.c.6545208.v1
https://doi.org/10.1158/1940-6207.c.6545208.v1
Autor:
Felipe Samaniego, Asif Rashid, Boris Blechacz, Anita L. Sabichi, Lei Feng, Xue Ao, Rong-Hua Tao, Tamer Khashab, Lalit Sehgal, Rohit Mathur, Zuzana Berkova, Haifeng Zhu
Supplementary figure legends and materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dab0254a818c31b3390df0b77e6be1ca
https://doi.org/10.1158/1541-7786.22513642.v1
https://doi.org/10.1158/1541-7786.22513642.v1
Autor:
John L. Clifford, Urska Cvek, Marjan Trutschl, Raja Loganantharaj, Michael S. Dai, Patrick Adegboyega, I-ling Lee, Jennifer Gill, Anita L. Sabichi, Randolph Stone
Supplementary Table 1 from Identification of Genes Correlated with Early-Stage Bladder Cancer Progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1749baad5f076239a1e9fa65d00caf0a
https://doi.org/10.1158/1940-6207.22523067.v1
https://doi.org/10.1158/1940-6207.22523067.v1
Autor:
Seth P. Lerner, J. Lynn Palmer, Jaye L. Viner, Craig Eagle, Jorge De la Cerda, Bogdan A. Czerniak, Ellen Richmond, Suyu Liu, H. Barton Grossman, J. Jack Lee, Anita L. Sabichi
Perspective on This Article from A Randomized Controlled Trial of Celecoxib to Prevent Recurrence of Nonmuscle-Invasive Bladder Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936b733203b98683bb3703c6709acba3
https://doi.org/10.1158/1940-6207.22526784.v1
https://doi.org/10.1158/1940-6207.22526784.v1